Show simple item record

dc.contributor.authorHaslett, Kate
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorKoh, P
dc.contributor.authorAshcroft, Linda
dc.contributor.authorAsselin, M
dc.contributor.authorDive, Caroline
dc.contributor.authorHarris, C
dc.contributor.authorJackson, Alan
dc.contributor.authorManoharan, Prakash
dc.contributor.authorMullan, Damian
dc.contributor.authorRyder, W David J
dc.contributor.authorTaylor, Benjamin
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2018-05-02T10:40:34Z
dc.date.available2018-05-02T10:40:34Z
dc.date.issued2018-01
dc.identifier.citationPhase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer 2018, 115:S65 Lung Canceren
dc.identifier.issn01695002
dc.identifier.doi10.1016/S0169-5002(18)30177-6
dc.identifier.urihttp://hdl.handle.net/10541/620948
dc.language.isoenen
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0169500218301776en
dc.rightsArchived with thanks to Lung Canceren
dc.titlePhase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung canceren
dc.typeMeetings and Proceedingsen
dc.contributor.departmentOncology, The University of Manchester, and The Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalLung Canceren


Files in this item

This item appears in the following Collection(s)

Show simple item record